Immunoglobulins comprising predominantly a Man3GlcNAc2 glycoform

Details for Australian Patent Application No. 2005269765 (hide)

Owner GlycoFi, Inc.

Inventors Li, Huijuan; Gerngross, Tillman U.; Wildt, Stefan

Agent Spruson & Ferguson

Pub. Number AU-A-2005269765

PCT Pub. Number WO2006/014685

Priority 60/589,937 21.07.04 US; 60/589,913 21.07.04 US

Filing date 19 July 2005

Wipo publication date 9 February 2006

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014685 Priority application(s): WO2006/014685

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269766-Multiple tip lancet

2005269763-Immunoglobulins comprising predominantly a Gal2GlcNac2Man3GlcNac2 glycoform